Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1995 1
2004 1
2005 1
2007 2
2008 1
2009 2
2010 4
2011 3
2012 7
2013 8
2014 5
2015 5
2016 1
2017 2
2018 3
2019 7
2020 4
2021 10
2022 13
2023 12
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Ligelizumab for Chronic Spontaneous Urticaria.
Maurer M, Giménez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, Bernstein JA, Brehler R, Chu CY, Chung WH, Danilycheva I, Grattan C, Hébert J, Katelaris C, Makris M, Meshkova R, Savic S, Sinclair R, Sitz K, Staubach P, Wedi B, Löffler J, Barve A, Kobayashi K, Hua E, Severin T, Janocha R. Maurer M, et al. Among authors: hua e. N Engl J Med. 2019 Oct 3;381(14):1321-1332. doi: 10.1056/NEJMoa1900408. N Engl J Med. 2019. PMID: 31577874 Free article. Clinical Trial.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Among authors: hua e. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Cellular rejuvenation protects neurons from inflammation mediated cell death.
Drake SS, Mohammadnia A, Heale K, Groh AMR, Hua EM, Zaman A, Hintermayer MA, Zandee S, Gosselin D, Stratton JA, Sinclair DA, Fournier AE. Drake SS, et al. Among authors: hua em. bioRxiv [Preprint]. 2023 Oct 2:2023.09.30.560301. doi: 10.1101/2023.09.30.560301. bioRxiv. 2023. PMID: 37873446 Free PMC article. Preprint.
2,3-Dihydro-1H-pyrrolizin-1-one.
Ali Y, Peng Y, Hua E, Anwar MA, Kalhoro MA. Ali Y, et al. Among authors: hua e. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 25;66(Pt 10):o2612. doi: 10.1107/S1600536810034902. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587587 Free PMC article.
3-Methyl-1H-pyrrolo[2,1-c][1,4]oxazin-1-one.
Khan ST, Yu P, Hua E, Ali SN, Nisa M. Khan ST, et al. Among authors: hua e. Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 27;66(Pt 3):o711. doi: 10.1107/S1600536810006951. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21580449 Free PMC article.
(E)-2-(2-Furylmethyl-idene)-2,3-dihydro-1H-pyrrolizin-1-one.
Ali Y, Yu P, Hua E, Rui G, Qi S. Ali Y, et al. Among authors: hua e. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 5;66(Pt 7):o1578. doi: 10.1107/S1600536810017939. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587819 Free PMC article.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Staubach P, Alvaro-Lozano M, Sekerel BE, Maurer M, Ben-Shoshan M, Porter M, Hua E, Ji Y, Burciu A, Savelieva M, Severin T, Drollmann A, Bienczak A. Staubach P, et al. Among authors: hua e. Pediatr Allergy Immunol. 2023 Jul;34(7):e13982. doi: 10.1111/pai.13982. Pediatr Allergy Immunol. 2023. PMID: 37492920 Clinical Trial.
Self-propelled motion controlled by ionic liquids.
Hua E, Gao J, Xu Y, Matsuo M, Nakata S. Hua E, et al. Phys Chem Chem Phys. 2024 Mar 6;26(10):8488-8493. doi: 10.1039/d3cp05630a. Phys Chem Chem Phys. 2024. PMID: 38411193
97 results